Prothena reported 36.5M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Agios Pharmaceuticals AGIO:US $ 45.79M 14.03M
Akebia Therapeutics AKBA:US $ 253.91M 2.58M
ALKERMES ALKS:US $ 462.36M 8.93M
Alnylam Pharmaceuticals ALNY:US $ 605.96M 89.75M
Amgen AMGN:US $ 12886M 702M
Biogen BIIB:US $ 3946.6M 351.6M
Biomarin Pharmaceutical BMRN:US $ 490.42M 49.4M
Bluebird Bio BLUE:US $ 142.89M 10.1M
Exelixis EXEL:US $ 289.08M 48.51M
Intercept Pharmaceuticals ICPT:US $ 151.04M 15.78M
Intra Cellular Therapies ITCI:US $ 59.07M 5.72M
IONIS PHARMACEUT IONS:US $ 228.45M 12.1M
Macrogenics MGNX:US $ 67.1M 7.48M
Nektar Therapeutics NKTR:US $ 105.28M 20.08M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Prothena PRTA:US 36.5M 3.04M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M
Seattle Genetics SGEN:US $ 531.29M 37.56M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Vertex Pharmaceuticals VRTX:US $ 2180.2M 38.2M
Vital Therapies VTL:US $ 11.46M 0.06M
Xoma XOMA:US $ 7.89M 5.08M
YTE INCY:US $ 886.16M 31.86M